272 related articles for article (PubMed ID: 36077291)
1. T-Type Calcium Channels: A Mixed Blessing.
Melgari D; Frosio A; Calamaio S; Marzi GA; Pappone C; Rivolta I
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077291
[TBL] [Abstract][Full Text] [Related]
2. A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry?
Gackière F; Bidaux G; Lory P; Prevarskaya N; Mariot P
Cell Calcium; 2006 Apr; 39(4):357-66. PubMed ID: 16442617
[TBL] [Abstract][Full Text] [Related]
3. A selective T-type Ca2+ channel blocker R(-) efonidipine.
Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483
[TBL] [Abstract][Full Text] [Related]
4. Role of membrane depolarization and T-type Ca2+ channels in angiotensin II and K+ stimulated aldosterone secretion.
Lotshaw DP
Mol Cell Endocrinol; 2001 Apr; 175(1-2):157-71. PubMed ID: 11325526
[TBL] [Abstract][Full Text] [Related]
5. T-Type Calcium Channel Inhibitors Induce Apoptosis in Medulloblastoma Cells Associated with Altered Metabolic Activity.
Sedeeq M; Maklad A; Dutta T; Feng Z; Wilson R; Gueven N; Azimi I
Mol Neurobiol; 2022 May; 59(5):2932-2945. PubMed ID: 35243582
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of effects of T and N type calcium channel blockers on the electroencephalogram recordings in Wistar Albino Glaxo/Rij rats, an absence epilepsy model.
Durmus N; Gültürk S; Kaya T; Demir T; Parlak M; Altun A
Indian J Pharmacol; 2015; 47(1):34-8. PubMed ID: 25821308
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.
Moosmang S; Haider N; Brüderl B; Welling A; Hofmann F
Circ Res; 2006 Jan; 98(1):105-10. PubMed ID: 16306443
[TBL] [Abstract][Full Text] [Related]
8. CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy.
Obradovic ALj; Hwang SM; Scarpa J; Hong SJ; Todorovic SM; Jevtovic-Todorovic V
PLoS One; 2014; 9(4):e91467. PubMed ID: 24705276
[TBL] [Abstract][Full Text] [Related]
9. Effect of mibefradil on sodium and calcium currents.
Strege PR; Bernard CE; Ou Y; Gibbons SJ; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G249-53. PubMed ID: 15790762
[TBL] [Abstract][Full Text] [Related]
10. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.
Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S
Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450
[TBL] [Abstract][Full Text] [Related]
11. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396.
Li M; Hansen JB; Huang L; Keyser BM; Taylor JT
Cardiovasc Drug Rev; 2005; 23(2):173-96. PubMed ID: 16007233
[TBL] [Abstract][Full Text] [Related]
12. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels.
Huang L; Keyser BM; Tagmose TM; Hansen JB; Taylor JT; Zhuang H; Zhang M; Ragsdale DS; Li M
J Pharmacol Exp Ther; 2004 Apr; 309(1):193-9. PubMed ID: 14718587
[TBL] [Abstract][Full Text] [Related]
13. Mibefradil, a T-type Ca
Li P; Rubaiy HN; Chen GL; Hallett T; Zaibi N; Zeng B; Saurabh R; Xu SZ
Br J Pharmacol; 2019 Oct; 176(19):3845-3856. PubMed ID: 31271653
[TBL] [Abstract][Full Text] [Related]
14. Voltage-gated calcium channel blockers deregulate macroautophagy in cardiomyocytes.
Pushparaj C; Das A; Purroy R; Nàger M; Herreros J; Pamplona R; Cantí C
Int J Biochem Cell Biol; 2015 Nov; 68():166-75. PubMed ID: 26429067
[TBL] [Abstract][Full Text] [Related]
15. Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons.
Wolfart J; Roeper J
J Neurosci; 2002 May; 22(9):3404-13. PubMed ID: 11978817
[TBL] [Abstract][Full Text] [Related]
16. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
Perez-Reyes E; Van Deusen AL; Vitko I
J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
[TBL] [Abstract][Full Text] [Related]
17. Effects of T-type calcium channel blockers on cocaine-induced hyperlocomotion and thalamocortical GABAergic abnormalities in mice.
Bisagno V; Raineri M; Peskin V; Wikinski SI; Uchitel OD; Llinás RR; Urbano FJ
Psychopharmacology (Berl); 2010 Oct; 212(2):205-14. PubMed ID: 20652540
[TBL] [Abstract][Full Text] [Related]
18. T-type calcium channels and tumor proliferation.
Panner A; Wurster RD
Cell Calcium; 2006 Aug; 40(2):253-9. PubMed ID: 16765439
[TBL] [Abstract][Full Text] [Related]
19. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Tompkins JD; Merriam LA; Girard BM; May V; Parsons RL
Am J Physiol Cell Physiol; 2015 Jun; 308(11):C857-66. PubMed ID: 25810261
[TBL] [Abstract][Full Text] [Related]
20. Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967).
Avdonin PV; Buhler FR; Tkachuk VA
Membr Cell Biol; 2000; 13(5):645-55. PubMed ID: 10987388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
